ReviewFrontiers in immunology2022

Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines.

Jianyang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.